130 related articles for article (PubMed ID: 31685616)
1.
Park MH; Lee M; Nam G; Kim M; Kang J; Choi BJ; Jeong MS; Park KH; Han WH; Tak E; Kim MS; Lee J; Lin Y; Lee YH; Song IS; Choi MK; Lee JY; Jin HK; Bae JS; Lim MH
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23426-23436. PubMed ID: 31685616
[TBL] [Abstract][Full Text] [Related]
2. Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice.
Lu J; Zhang J; Wang X; Yuan F; Xin B; Li J; Yang Q; Li X; Zhang J; Wang X; Fu J; Guo C
Brain Res Bull; 2024 Jun; 212():110969. PubMed ID: 38705540
[TBL] [Abstract][Full Text] [Related]
3. Potential Alzheimer's disease drug targets identified through microglial biology research.
Lepiarz-Raba I; Hidayat T; Hannan AJ; Jawaid A
Expert Opin Drug Discov; 2024 May; 19(5):587-602. PubMed ID: 38590098
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific effects of ethanol consumption in older Fischer 344 rats on microglial dynamics and Aβ
Marsland P; Vore AS; DaPrano E; Paluch JM; Blackwell AA; Varlinskaya EI; Deak T
Alcohol; 2023 Mar; 107():108-118. PubMed ID: 36155778
[TBL] [Abstract][Full Text] [Related]
5. Signalling Pathways Involved in Microglial Activation in Alzheimer's Disease and Potential Neuroprotective Role of Phytoconstituents.
Ali MU; Anwar L; Ali MH; Iqubal MK; Iqubal A; Baboota S; Ali J
CNS Neurol Disord Drug Targets; 2024; 23(7):819-840. PubMed ID: 36567300
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches.
Chen H; Zeng Y; Wang D; Li Y; Xing J; Zeng Y; Liu Z; Zhou X; Fan H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611758
[TBL] [Abstract][Full Text] [Related]
7. Oligomer-Aβ42 suppress glioma progression via potentiating phagocytosis of microglia.
Lu J; Wang Z; He Z; Hu Y; Duan H; Liu Z; Li D; Zhong S; Ren J; Zhao G; Mou Y; Yao M
CNS Neurosci Ther; 2024 Jan; 30(1):e14495. PubMed ID: 37849438
[TBL] [Abstract][Full Text] [Related]
8. Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer's disease.
Wang Y; Du Y; Huang H; Cao Y; Pan K; Zhou Y; He J; Yao W; Chen S; Gao X
Pharmacol Res; 2024 Apr; 202():107133. PubMed ID: 38458367
[TBL] [Abstract][Full Text] [Related]
9. A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms.
Derrick JS; Kerr RA; Nam Y; Oh SB; Lee HJ; Earnest KG; Suh N; Peck KL; Ozbil M; Korshavn KJ; Ramamoorthy A; Prabhakar R; Merino EJ; Shearer J; Lee JY; Ruotolo BT; Lim MH
J Am Chem Soc; 2015 Nov; 137(46):14785-97. PubMed ID: 26575890
[TBL] [Abstract][Full Text] [Related]
10. N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease.
Lee JY; Han SH; Park MH; Song IS; Choi MK; Yu E; Park CM; Kim HJ; Kim SH; Schuchman EH; Jin HK; Bae JS
Nat Commun; 2020 May; 11(1):2358. PubMed ID: 32398649
[TBL] [Abstract][Full Text] [Related]
11. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease.
Gate D; Saligrama N; Leventhal O; Yang AC; Unger MS; Middeldorp J; Chen K; Lehallier B; Channappa D; De Los Santos MB; McBride A; Pluvinage J; Elahi F; Tam GK; Kim Y; Greicius M; Wagner AD; Aigner L; Galasko DR; Davis MM; Wyss-Coray T
Nature; 2020 Jan; 577(7790):399-404. PubMed ID: 31915375
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome activation drives tau pathology.
Ising C; Venegas C; Zhang S; Scheiblich H; Schmidt SV; Vieira-Saecker A; Schwartz S; Albasset S; McManus RM; Tejera D; Griep A; Santarelli F; Brosseron F; Opitz S; Stunden J; Merten M; Kayed R; Golenbock DT; Blum D; Latz E; Buée L; Heneka MT
Nature; 2019 Nov; 575(7784):669-673. PubMed ID: 31748742
[TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease.
Lonnemann N; Hosseini S; Marchetti C; Skouras DB; Stefanoni D; D'Alessandro A; Dinarello CA; Korte M
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32145-32154. PubMed ID: 33257576
[TBL] [Abstract][Full Text] [Related]
14. Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life.
Uhlmann RE; Rother C; Rasmussen J; Schelle J; Bergmann C; Ullrich Gavilanes EM; Fritschi SK; Buehler A; Baumann F; Skodras A; Al-Shaana R; Beschorner N; Ye L; Kaeser SA; Obermüller U; Christensen S; Kartberg F; Stavenhagen JB; Rahfeld JU; Cynis H; Qian F; Weinreb PH; Bussiere T; Walker LC; Staufenbiel M; Jucker M
Nat Neurosci; 2020 Dec; 23(12):1580-1588. PubMed ID: 33199898
[TBL] [Abstract][Full Text] [Related]
15. A Glycosylated Prodrug to Attenuate Neuroinflammation and Improve Cognitive Deficits in Alzheimer's Disease Transgenic Mice.
Kim M; Park MH; Nam G; Lee M; Kang J; Song IS; Choi MK; Jin HK; Bae JS; Lim MH
Mol Pharm; 2021 Jan; 18(1):101-112. PubMed ID: 33241681
[TBL] [Abstract][Full Text] [Related]
16. SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.
Kwon OC; Song JJ; Yang Y; Kim SH; Kim JY; Seok MJ; Hwang I; Yu JW; Karmacharya J; Maeng HJ; Kim J; Jho EH; Ko SY; Son H; Chang MY; Lee SH
EMBO Mol Med; 2021 Apr; 13(4):e13076. PubMed ID: 33646633
[TBL] [Abstract][Full Text] [Related]
17. NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer's disease.
He XF; Xu JH; Li G; Li MY; Li LL; Pei Z; Zhang LY; Hu XQ
Cell Death Dis; 2020 Oct; 11(10):849. PubMed ID: 33051464
[TBL] [Abstract][Full Text] [Related]
18. β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer's disease pathology.
Shippy DC; Wilhelm C; Viharkumar PA; Raife TJ; Ulland TK
J Neuroinflammation; 2020 Sep; 17(1):280. PubMed ID: 32958021
[TBL] [Abstract][Full Text] [Related]
19. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.
Roy ER; Wang B; Wan YW; Chiu G; Cole A; Yin Z; Propson NE; Xu Y; Jankowsky JL; Liu Z; Lee VM; Trojanowski JQ; Ginsberg SD; Butovsky O; Zheng H; Cao W
J Clin Invest; 2020 Apr; 130(4):1912-1930. PubMed ID: 31917687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
